You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1062 GI-102, a novel CD80-IgG4-IL2v3 fusion protein driving lymphocyte expansion and anti-cancer potential through regulation of immune cells in the tumor microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1062 GI-102, a novel CD80-IgG4-IL2v3 fusion protein driving lymphocyte expansion and anti-cancer potential through regulation of immune cells in the tumor microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023160023
Dec 202396011
Jan 20244905
Feb 20243808
Mar 20249007
Apr 20247409
May 202492020
Jun 2024124012
Jul 2024106011
Aug 20246004
Sep 20243607
Oct 202464018
Nov 202468022
Dec 202466020
Jan 202558016
Feb 202518014
Mar 20250016
Apr 2025003
May 20250018
Jun 2025007
Total11990251